The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Intra-Cellular Therapies Inc shares valued at $4,375,659 were sold by Mates Sharon on Dec 04 ’24. At $85.80 per share, Mates Sharon sold 51,000 shares. The insider’s holdings dropped to 1,070,329 shares worth approximately $88.37 million following the completion of this transaction.
Also, Mates Sharon sold 51,697 shares, netting a total of over 4,346,842 in proceeds. Following the sale of shares at $84.08 each, the insider now holds 1,070,329 shares.
Before that, Mates Sharon had added 51,697 shares to its account. In a trade valued at $4,343,616, the Officer bought Intra-Cellular Therapies Inc shares for $84.02 each.
As published in a research note from Piper Sandler on September 06, 2024, Intra-Cellular Therapies Inc [ITCI] has been rated up from a Neutral to an Overweight and the price target has been revised to $92 from $68. Analysts at Robert W. Baird started covering the stock with ‘”an Outperform”‘ outlook in a report released in early January. As of December 11, 2023, TD Cowen has initiated its “an Outperform” rating for ITCI. Earlier on April 20, 2023, Morgan Stanley initiated its rating. Their recommendation was “an Overweight” for ITCI stock.
Analyzing ITCI Stock Performance
During the last five days, there has been a drop of approximately -1.15%. Over the course of the year, Intra-Cellular Therapies Inc shares have dropped approximately -1.15%. Shares of the company reached a 52-week high of $84.99 on 01/02/25 and a 52-week low of $80.82 on 01/07/25. A 50-day SMA is recorded $85.12, while a 200-day SMA reached $75.64. Nevertheless, trading volume fell to 0.42 million shares from 0.72 million shares the previous day.
Support And Resistance Levels for Intra-Cellular Therapies Inc (ITCI)
According to the 24-hour chart, there is a support level at 81.93, which, if violated, would cause prices to drop to 81.30. In the upper region, resistance lies at 83.12. The next price resistance is at 83.68. RSI (Relative Strength Index) is 44.46 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.54, which suggests the price will decrease in the coming days. Percent R is at 79.08%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
